Gloria Melanie 4

4 · Immunovant, Inc. · Filed Apr 9, 2026

AI-generated summary of this filing

Updated Apr 9, 2026

Immunovant (IMVT) COO Gloria Melanie Receives Awards

What Happened

Gloria Melanie, Chief Operating Officer of Immunovant, was granted equity awards on April 7, 2026: 83,671 restricted stock units (RSUs) and 121,063 option awards (reported as a derivative). Both grants are reported at $0.00 cash consideration (typical for compensatory awards), so there was no purchase price paid by the insider.

Key Details

Transaction date: 2026-04-07; Filing date (Form 4): 2026-04-09 (filed within the typical 2-business-day Form 4 deadline).
Reported consideration: $0.00 for both the RSUs and the option awards (code A = award/grant).
Vesting (per filing footnotes):
- RSUs: 25% vest on April 1, 2027; remaining 75% vest in 12 substantially equal quarterly installments thereafter, subject to continued service.
- Options: 25% vest on April 1, 2027; remaining 75% vest in 36 substantially equal monthly installments thereafter, subject to continued service.
Shares owned after the transactions: not provided in the excerpt of the filing.
No indication in the filing that awards were part of a 10b5-1 plan, a gift, a sale, or an exercise — these are compensatory grants.

Context

RSUs are promises to deliver shares upon vesting; option awards are derivative rights to acquire shares in the future once vested. Neither represents an immediate sale or purchase of shares by the insider.
These types of awards are standard executive compensation and do not by themselves signal buying or selling intent. Vesting is tied to continued service, so the economic benefit to the insider depends on future vesting and company stock performance.

Form 4

Period: 2026-04-07

Chief Operating Officer

Transactions

Award
Common Stock
[F1]
2026-04-07+83,671→ 253,944 total
Award
Stock Option (right to buy)
[F2]
2026-04-07+121,063→ 121,063 total
Exercise: $24.61Exp: 2036-04-07→ Common Stock (121,063 underlying)

Footnotes (2)

[F1]These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.
[F2]These options were granted pursuant to the Plan. The shares underlying the options will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in thirty-six (36) successive substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.

Signature

/s/ Tiago Girao, attorney-in-fact for Melanie Gloria|2026-04-09

1 file